Etanercept for the Treatment of Lupus Nephritis

NCT00447265 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

NIH

Sponsor class

Stopped The perceived risk-benefit ratio for individuals with early active RA

Conditions

Lupus Nephritis

Interventions

DRUG: Etanercept
DRUG: Lupus Treatment- Standard of Care
DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)